301 related articles for article (PubMed ID: 33781552)
21. FGF23 and the parathyroid glands.
Silver J; Naveh-Many T
Pediatr Nephrol; 2010 Nov; 25(11):2241-5. PubMed ID: 20526631
[TBL] [Abstract][Full Text] [Related]
22. Fgf23 and parathyroid hormone signaling interact in kidney and bone.
Andrukhova O; Streicher C; Zeitz U; Erben RG
Mol Cell Endocrinol; 2016 Nov; 436():224-39. PubMed ID: 27498418
[TBL] [Abstract][Full Text] [Related]
23. Klotho/FGF23 Axis in CKD.
Tsuchiya K; Nagano N; Nitta K
Contrib Nephrol; 2015; 185():56-65. PubMed ID: 26023015
[TBL] [Abstract][Full Text] [Related]
24. Role of αKlotho and FGF23 in regulation of type II Na-dependent phosphate co-transporters.
Hu MC; Shi M; Moe OW
Pflugers Arch; 2019 Jan; 471(1):99-108. PubMed ID: 30506274
[TBL] [Abstract][Full Text] [Related]
25. Roles of PTH and FGF23 in kidney failure: a focus on nonclassical effects.
Komaba H
Clin Exp Nephrol; 2023 May; 27(5):395-401. PubMed ID: 36977891
[TBL] [Abstract][Full Text] [Related]
26. Intact FGF23 and α-Klotho during acute inflammation/sepsis in CKD patients.
Dounousi E; Torino C; Pizzini P; Cutrupi S; Panuccio V; D'Arrigo G; Abd ElHafeez S; Tripepi G; Mallamaci F; Zoccali C
Eur J Clin Invest; 2016 Mar; 46(3):234-41. PubMed ID: 26728476
[TBL] [Abstract][Full Text] [Related]
27. FGF23 fails to inhibit uremic parathyroid glands.
Canalejo R; Canalejo A; Martinez-Moreno JM; Rodriguez-Ortiz ME; Estepa JC; Mendoza FJ; Munoz-Castaneda JR; Shalhoub V; Almaden Y; Rodriguez M
J Am Soc Nephrol; 2010 Jul; 21(7):1125-35. PubMed ID: 20431039
[TBL] [Abstract][Full Text] [Related]
28. Klotho and endocrine fibroblast growth factors: markers of chronic kidney disease progression and cardiovascular complications?
Kuro-O M
Nephrol Dial Transplant; 2019 Jan; 34(1):15-21. PubMed ID: 29800324
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease.
Singh S; Grabner A; Yanucil C; Schramm K; Czaya B; Krick S; Czaja MJ; Bartz R; Abraham R; Di Marco GS; Brand M; Wolf M; Faul C
Kidney Int; 2016 Nov; 90(5):985-996. PubMed ID: 27457912
[TBL] [Abstract][Full Text] [Related]
30. Deregulated Renal Calcium and Phosphate Transport during Experimental Kidney Failure.
Pulskens WP; Verkaik M; Sheedfar F; van Loon EP; van de Sluis B; Vervloet MG; Hoenderop JG; Bindels RJ;
PLoS One; 2015; 10(11):e0142510. PubMed ID: 26566277
[TBL] [Abstract][Full Text] [Related]
31. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.
Isakova T; Wahl P; Vargas GS; Gutiérrez OM; Scialla J; Xie H; Appleby D; Nessel L; Bellovich K; Chen J; Hamm L; Gadegbeku C; Horwitz E; Townsend RR; Anderson CA; Lash JP; Hsu CY; Leonard MB; Wolf M
Kidney Int; 2011 Jun; 79(12):1370-8. PubMed ID: 21389978
[TBL] [Abstract][Full Text] [Related]
32. New Aspects of the Kidney in the Regulation of Fibroblast Growth Factor 23 (FGF23) and Mineral Homeostasis.
Mace ML; Olgaard K; Lewin E
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233840
[TBL] [Abstract][Full Text] [Related]
33. Regulation of parathyroid function in chronic kidney disease (CKD).
Fukagawa M; Nakanishi S; Fujii H; Hamada Y; Abe T
Clin Exp Nephrol; 2006 Sep; 10(3):175-9. PubMed ID: 17009074
[TBL] [Abstract][Full Text] [Related]
34. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
35.
Shilo V; Mor-Yosef Levi I; Abel R; Mihailović A; Wasserman G; Naveh-Many T; Ben-Dov IZ
J Am Soc Nephrol; 2017 Aug; 28(8):2353-2363. PubMed ID: 28298326
[TBL] [Abstract][Full Text] [Related]
36. [Role of parathyroid hormone in Klotho-FGF23 system].
Kimura T; Shiizaki K; Kuro-O M
Clin Calcium; 2016 Jun; 26(6):859-66. PubMed ID: 27230841
[TBL] [Abstract][Full Text] [Related]
37. Phosphate acts directly on the calcium-sensing receptor to stimulate parathyroid hormone secretion.
Centeno PP; Herberger A; Mun HC; Tu C; Nemeth EF; Chang W; Conigrave AD; Ward DT
Nat Commun; 2019 Oct; 10(1):4693. PubMed ID: 31619668
[TBL] [Abstract][Full Text] [Related]
38. Dietary phosphate restriction suppresses phosphaturia but does not prevent FGF23 elevation in a mouse model of chronic kidney disease.
Zhang S; Gillihan R; He N; Fields T; Liu S; Green T; Stubbs JR
Kidney Int; 2013 Oct; 84(4):713-21. PubMed ID: 23698235
[TBL] [Abstract][Full Text] [Related]
39. FGF23 and the parathyroid.
Silver J; Naveh-Many T
Adv Exp Med Biol; 2012; 728():92-9. PubMed ID: 22396164
[TBL] [Abstract][Full Text] [Related]
40. Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease.
Stubbs JR; He N; Idiculla A; Gillihan R; Liu S; David V; Hong Y; Quarles LD
J Bone Miner Res; 2012 Jan; 27(1):38-46. PubMed ID: 22031097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]